Literature DB >> 1960383

Combination of fluoxetine with pemoline in the treatment of major depressive disorder.

A Metz1, R I Shader.   

Abstract

Standard antidepressant drug treatments are unsuccessful in treating up to one-third of depressed patients. The authors describe the utility of combining the 5-hydroxytryptamine (5-HT) re-uptake blocker, fluoxetine (Prozac) with a psychostimulant, pemoline (Cylert), for some of these patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1960383     DOI: 10.1097/00004850-199100620-00003

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  2 in total

1.  Pemoline augmentation for resistant depression.

Authors:  F Benazzi
Journal:  J Psychiatry Neurosci       Date:  1997-01       Impact factor: 6.186

2.  Effectiveness of methylphenidate as augmentation therapy after failure of adjunctive neuromodulation for patients with treatment-refractory bipolar depression: a case report.

Authors:  Marc Adida; Jean-Michel Azorin
Journal:  Neuropsychiatr Dis Treat       Date:  2014-04-02       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.